Navigation Links
Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)
Date:6/24/2009

Partnership will offer expanded access to choice, quality and cost-efficiency for patients and payers

WICHITA, Kan. and AVENTURA, Fla., June 24 /PRNewswire/ -- Galichia Heart Hospital and Mobile Surgery International (MSI) have reached an agreement for Galichia to host MSI-coordinated, highly specialized, urologic surgical teams at its facilities in Wichita. This agreement, effective immediately, expands Galichia's capabilities as a center of excellence for selected types of specialty surgical care and expands MSI's ability to offer patients surgical choice in high quality facilities across the United States.

"This agreement with Mobile Surgery International has brought us immediate access to an advanced urologic cancer surgical program with no learning curve and little capital risk," said Stephen Harris, chief executive officer of Galichia Heart Hospital. "We have previously proven that Galichia is a medical destination for certain types of cardiovascular conditions. Now we are expanding the services we offer to patients, both locally and globally."

MSI will initially offer minimally invasive surgical services for prostate cancer and other forms of prostate surgery at Galichia. Additional services at Galichia may be made available through MSI over time.

"We are delighted to have implemented this agreement because Galichia Heart Hospital offered us the quality of surgical capabilities and facilities we consider essential," said Dr. Arnon Krongrad, chairman and chief executive officer of Mobile Surgery International. "The hospital's location in Wichita will be a convenient destination for many of the patients that MSI expects to treat, making it easier for patients to travel to and from such a center of excellence."

MSI continues to form relationships that will allow payers to fill gaps in network coverage and offer choice, quality and cost containment to their patient base. Some of these relationships will specifically include referrals of patients to MSI for certain urological procedures at Galichia Heart Hospital.

In March 2009, Mobile Surgery International first demonstrated the ability of a mobile surgical model to simultaneously deliver choice, quality, and cost containment to patients. It sent an uninsured American and his American surgical team to Trinidad in the West Indies. In so doing, MSI delivered the treatment the patient chose and cut his cost by more than half.

Galichia Heart Hospital is an 82-bed full-service, acute care hospital located in Wichita, Kan. With a staff of more than 150 physicians, the hospital is committed to world class care and improved efficiency in all areas of patient treatment and care. Specialties include cardiology, interventional cardiology, diagnostic radiology, nephrology, emergency medicine, nuclear cardiology, electrophysiology, interventional vascular medicine, gastroenterology, orthopedics, general surgery, sleep disorders, internal medicine, family practice and endocrinology.

Mobile Surgery International offers patients and payers from anywhere in the world surgical choice and quality with cost containment through its Centers of Excellence with Global Convenience(TM). To do this, MSI is cutting overhead, recruiting outstanding surgical talent, and identifying host surgical facilities. It provides differentiating surgical programs and develops custom solutions to administrative needs with minimal regard to geography. Whether the patient comes to the surgeon, the surgeon goes to the patient, or patient and surgeon meet at a mutually convenient location, MSI coordinates all necessary arrangements at a cost agreeable to the patient and/or the payer. MSI is an operational unit of the Krongrad Institute. For more information, see www.emeseye.com.

    Media contacts:

    Galichia Heart Hospital:
    Alisa Crawford, VP Business Development
    Direct: (316) 858-8511
    acrawford@ghhospital.com

    Mobile Surgery International:
    Arnon Krongrad, MD
    Cell: (305) 790-2363
    ak@emeseye.com


'/>"/>
SOURCE Mobile Surgery International
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Scientists identify gene vital to early embryonic cells forming a normal heart and skull
2. Berlin Heart Inc. Receives FDA Orphan Product Development Grant
3. PeriCor Therapeutics Reports Positive Preclinical Results of GP531 at the European Heart Failure Congress in Nice
4. 500th Patient Receives Berlin Heart EXCOR Pediatric Ventricular Assist Device
5. Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
6. Nile Therapeutics CD-NP Clinical Program for Acute Heart Failure Released From Clinical Hold by FDA
7. Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients
8. Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions
9. deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
10. Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)
11. Symphony Medical Announces First Patient Successfully Treated With Novel Congestive Heart Failure Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... San Francisco, CA (PRWEB) , ... February 04, ... ... future of enterprise talent development and compliance training, today announced an interactive ... on Morf Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course ...
(Date:2/4/2016)... Feb. 4, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today that Edward Lanphier , Sangamo,s president and ... progress of Sangamo,s ZFP Therapeutic ® development programs ... 2:40 pm ET on Thursday, February 11, 2016, at ... Conference. The conference is being held in ...
(Date:2/4/2016)... ... February 04, 2016 , ... ... Forensics Club, takes place February 5-6 at the University’s student center, Kehr ... activities such as workshops and competitions for ample networking, learning and collaborating ...
(Date:2/4/2016)... 2016  CytoSorbents Corporation (NASDAQ: CTSO ), ... CytoSorb® blood filter to treat deadly inflammation in ... announced that CEO Dr. Phillip Chan , ... Group,s 2016 Disruptive Growth & Healthcare Conference, providing ... Conference Presentation Details: Where: Convene Conference ...
Breaking Biology Technology:
(Date:2/3/2016)... , February 3, 2016 ... market research report "Automated Fingerprint Identification System Market by ... Search), Application (Banking & Finance, Government, Healthcare, and Transportation) ... MarketsandMarkets, the market is expected to be worth USD ... 21.0% between 2015 and 2020. The transformation and technology ...
(Date:2/2/2016)... This BCC Research report provides a ... the recent advances in high throughput ‘omic platforms ... forward. Includes forecast through 2019. Use ... opportunities that exist in the bioinformatic market. Analyze ... well as IT and bioinformatics service providers. Analyze ...
(Date:2/2/2016)... , Feb. 2, 2016  Based on ... Frost & Sullivan recognizes US-based Intelligent Retinal Imaging ... & Sullivan Award for New Product Innovation. IRIS, ... North America , is poised ... rapidly growing diabetic retinopathy market. The IRIS technology ...
Breaking Biology News(10 mins):